« Futuretec raises $7,950,000
Attributor raises $12,000,000 »

CoAxia raises $11,500,000

April 2, 2008
 VCA Theme: Preventing Heart Attack and Stroke

CoAxia, Inc. of Maple Grove, MN, today announced the closing of an additional $11.5M financing from current investors to support the continuation of CoAxia’s ongoing clinical trials.  The investment is an extension of the previously announced C Round and will allow CoAxia to continue its SENTIS pivotal FDA trial of NeuroFlo Perfusion Augmentation Therapy in acute ischemic stroke, as well as other ongoing feasibility studies to evaluate use of the same technology in additional stroke populations.  “NeuroFlo technology has the potential to be widely applied in ischemic stroke — with major benefit to stroke patients.”